A detailed history of Wells Fargo & Company transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 27,614 shares of PCRX stock, worth $537,644. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,614
Previous 47,383 41.72%
Holding current value
$537,644
Previous $1.36 Million 69.37%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$11.7 - $28.46 $231,297 - $562,625
-19,769 Reduced 41.72%
27,614 $415,000
Q2 2024

Aug 13, 2024

BUY
$25.5 - $31.51 $167,917 - $207,493
6,585 Added 16.14%
47,383 $1.36 Million
Q1 2024

May 10, 2024

BUY
$27.7 - $35.48 $103,099 - $132,056
3,722 Added 10.04%
40,798 $1.19 Million
Q4 2023

Feb 09, 2024

BUY
$26.32 - $34.31 $228,852 - $298,325
8,695 Added 30.64%
37,076 $1.25 Million
Q3 2023

Nov 13, 2023

SELL
$30.68 - $40.09 $381,383 - $498,358
-12,431 Reduced 30.46%
28,381 $870,000
Q2 2023

Aug 15, 2023

SELL
$36.12 - $47.5 $1.38 Million - $1.82 Million
-38,285 Reduced 48.4%
40,812 $1.64 Million
Q1 2023

May 12, 2023

BUY
$35.53 - $43.38 $50,914 - $62,163
1,433 Added 1.85%
79,097 $3.23 Million
Q4 2022

Feb 13, 2023

SELL
$38.19 - $57.45 $81,955 - $123,287
-2,146 Reduced 2.69%
77,664 $3 Million
Q3 2022

Nov 14, 2022

SELL
$51.24 - $58.89 $209,930 - $241,272
-4,097 Reduced 4.88%
79,810 $4.25 Million
Q2 2022

Aug 12, 2022

BUY
$51.49 - $81.64 $219,295 - $347,704
4,259 Added 5.35%
83,907 $4.89 Million
Q1 2022

May 16, 2022

SELL
$60.03 - $76.49 $196,358 - $250,198
-3,271 Reduced 3.94%
79,648 $6.08 Million
Q4 2021

Feb 14, 2022

SELL
$47.97 - $62.21 $15.6 Million - $20.3 Million
-325,792 Reduced 79.71%
82,919 $4.99 Million
Q3 2021

Nov 15, 2021

SELL
$54.64 - $61.3 $21 Million - $23.6 Million
-384,843 Reduced 48.5%
408,711 $22.9 Million
Q2 2021

Aug 16, 2021

SELL
$59.18 - $69.99 $45.8 Million - $54.2 Million
-774,020 Reduced 49.38%
793,554 $48.2 Million
Q1 2021

May 13, 2021

BUY
$59.31 - $78.82 $10.1 Million - $13.4 Million
169,600 Added 12.13%
1,567,574 $110 Million
Q4 2020

Feb 09, 2021

BUY
$50.47 - $66.26 $29.5 Million - $38.7 Million
584,374 Added 71.83%
1,397,974 $83.7 Million
Q3 2020

Nov 05, 2020

BUY
$51.97 - $63.0 $15.5 Million - $18.8 Million
298,412 Added 57.92%
813,600 $48.9 Million
Q2 2020

Aug 13, 2020

BUY
$30.8 - $52.47 $11.2 Million - $19 Million
362,934 Added 238.37%
515,188 $27 Million
Q1 2020

May 14, 2020

BUY
$28.4 - $50.7 $4.32 Million - $7.72 Million
152,254 New
152,254 $5.11 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.